Delivery Order SPE2DB20D2104-SPE2DB21FT89A
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,205.58, is for the delivery of Mupirocin 2% Cream in 15-gram quantities. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) and the DLA, valued at up to $999,999,999.00 and running through November...
- This federal contract award, valued at $1,704.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a topical antibiotic medication, with an ultimate completion date of April 11, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of mupirocin 2% cream (15 gm). The contract has a firm fixed price of $2,168.80 and a period of performance through August 10, 2023. This is a delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,358.08 delivery order is for Mupirocin 2% Cream, 15 gram, a topical antibiotic ointment. The contract has a firm fixed price pricing type and an ultimate completion date of December 13, 2021. This contract is not designated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $4,142.15, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, with a completion date of May 24, 2023. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $3,957.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream in 15 gram tubes. This is a firm fixed-price delivery order contract with a completion date of September 10, 2024. The contract has no set-aside designation, indicating it was open to full and open competition. AmerisourceBergen, a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,541.14 firm-fixed-price delivery order is for the supply of 4554785500 - Mupirocin 2% Cream 15GM, with a completion date of September 15, 2021. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,562.44, is for the delivery of 4566490563 - Mupirocin 2% Cream 15GM. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of November 20, 2024. The award date is November 19, 2024. This contract does not have a set-aside designation....
- This federal contract award, valued at $5,052.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of Mupirocin 2% Cream, a prescription pharmaceutical product. It is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2023. The contract was awarded on October 24, 2023 and was not set aside for any specific business category....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,598.68, is for the delivery of Mupirocin 2% Cream 15GM, a topical antibiotic medication. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT89ADelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream 15GM. The contract, valued at $4,131.32, is a delivery order awarded on September 8, 2021, with a completion date of September 9, 2021. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, running through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/8/21 |